A detailed history of Mendel Money Management transactions in Abbott Laboratories stock. As of the latest transaction made, Mendel Money Management holds 5,538 shares of ABT stock, worth $649,385. This represents 0.29% of its overall portfolio holdings.

Number of Shares
5,538
Previous 7,541 26.56%
Holding current value
$649,385
Previous $783,000 19.41%
% of portfolio
0.29%
Previous 0.38%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$100.07 - $118.13 $200,440 - $236,614
-2,003 Reduced 26.56%
5,538 $631,000
Q2 2024

Aug 13, 2024

SELL
$100.73 - $112.44 $36,061 - $40,253
-358 Reduced 4.53%
7,541 $783,000
Q1 2024

May 01, 2024

SELL
$109.52 - $120.96 $13,909 - $15,361
-127 Reduced 1.58%
7,899 $897,000
Q4 2023

Feb 14, 2024

BUY
$90.19 - $110.4 $723,864 - $886,070
8,026 New
8,026 $883,000
Q3 2023

Nov 13, 2023

BUY
$95.53 - $114.62 $23,882 - $28,655
250 Added 10.94%
2,535 $245,000
Q2 2023

Aug 14, 2023

BUY
$100.78 - $112.29 $503 - $561
5 Added 0.22%
2,285 $249,000
Q1 2023

May 10, 2023

SELL
$96.86 - $114.01 $735,361 - $865,563
-7,592 Reduced 76.9%
2,280 $230,000
Q4 2022

Feb 13, 2023

SELL
$95.06 - $111.52 $3,802 - $4,460
-40 Reduced 0.4%
9,872 $1.08 Million
Q3 2022

Nov 14, 2022

BUY
$96.76 - $112.03 $3,870 - $4,481
40 Added 0.41%
9,912 $959,000
Q1 2022

May 16, 2022

BUY
$114.02 - $139.04 $145,033 - $176,858
1,272 Added 14.79%
9,872 $1.17 Million
Q4 2019

Feb 13, 2020

SELL
$78.51 - $87.4 $7,851 - $8,740
-100 Reduced 1.15%
8,600 $747,000
Q3 2019

Nov 08, 2019

SELL
$81.84 - $88.74 $11,048 - $11,979
-135 Reduced 1.53%
8,700 $728,000
Q2 2019

Aug 08, 2019

BUY
$72.88 - $85.0 $2,550 - $2,975
35 Added 0.4%
8,835 $743,000
Q4 2017

Feb 06, 2018

BUY
$53.68 - $57.47 $472,384 - $505,736
8,800
8,800 $502,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $205B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Mendel Money Management Portfolio

Follow Mendel Money Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mendel Money Management, based on Form 13F filings with the SEC.

News

Stay updated on Mendel Money Management with notifications on news.